nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ABCC1—breast cancer	0.166	0.584	CbGaD
Probenecid—CYP3A4—breast cancer	0.0437	0.154	CbGaD
Probenecid—ALB—breast cancer	0.0382	0.134	CbGaD
Probenecid—ABCB1—breast cancer	0.0364	0.128	CbGaD
Probenecid—ABCC11—Methotrexate—breast cancer	0.0252	0.0528	CbGbCtD
Probenecid—ABCC6—Vinblastine—breast cancer	0.0244	0.051	CbGbCtD
Probenecid—ABCC1—Idarubicin—breast cancer	0.0239	0.0499	CbGbCtD
Probenecid—SLCO1A2—Chlorambucil—breast cancer	0.0213	0.0446	CbGbCtD
Probenecid—ABCC5—Fluorouracil—breast cancer	0.0201	0.042	CbGbCtD
Probenecid—ABCC6—Doxorubicin—breast cancer	0.015	0.0313	CbGbCtD
Probenecid—ABCC3—Fluorouracil—breast cancer	0.0126	0.0264	CbGbCtD
Probenecid—SLC16A1—Methotrexate—breast cancer	0.0111	0.0232	CbGbCtD
Probenecid—SLCO1C1—Methotrexate—breast cancer	0.0111	0.0232	CbGbCtD
Probenecid—ABCC1—Mitoxantrone—breast cancer	0.0103	0.0215	CbGbCtD
Probenecid—SLC22A7—Fluorouracil—breast cancer	0.00988	0.0207	CbGbCtD
Probenecid—ABCC4—Fluorouracil—breast cancer	0.00965	0.0202	CbGbCtD
Probenecid—ABCC1—Epirubicin—breast cancer	0.00831	0.0174	CbGbCtD
Probenecid—ABCC1—Paclitaxel—breast cancer	0.00819	0.0171	CbGbCtD
Probenecid—ABCC1—Irinotecan—breast cancer	0.00808	0.0169	CbGbCtD
Probenecid—CYP2C9—Anastrozole—breast cancer	0.00783	0.0164	CbGbCtD
Probenecid—ABCC2—Tamoxifen—breast cancer	0.00779	0.0163	CbGbCtD
Probenecid—SLC22A7—Docetaxel—breast cancer	0.00754	0.0158	CbGbCtD
Probenecid—CYP2C8—Lapatinib—breast cancer	0.00749	0.0157	CbGbCtD
Probenecid—ABCC3—Doxorubicin—breast cancer	0.00719	0.015	CbGbCtD
Probenecid—ABCC1—Vinblastine—breast cancer	0.00719	0.015	CbGbCtD
Probenecid—ABCC3—Methotrexate—breast cancer	0.00697	0.0146	CbGbCtD
Probenecid—ABCB1—Toremifene—breast cancer	0.00695	0.0145	CbGbCtD
Probenecid—SLC22A2—Vinblastine—breast cancer	0.00652	0.0136	CbGbCtD
Probenecid—CYP2C19—Lapatinib—breast cancer	0.00629	0.0132	CbGbCtD
Probenecid—ABCC2—Paclitaxel—breast cancer	0.00607	0.0127	CbGbCtD
Probenecid—CYP3A4—Exemestane—breast cancer	0.00601	0.0126	CbGbCtD
Probenecid—ABCC2—Irinotecan—breast cancer	0.00598	0.0125	CbGbCtD
Probenecid—CYP2C9—Idarubicin—breast cancer	0.00594	0.0124	CbGbCtD
Probenecid—ABCC1—Docetaxel—breast cancer	0.00592	0.0124	CbGbCtD
Probenecid—SLC22A11—Methotrexate—breast cancer	0.00572	0.012	CbGbCtD
Probenecid—ABCC2—Carboplatin—breast cancer	0.00571	0.0119	CbGbCtD
Probenecid—CYP2C8—Raloxifene—breast cancer	0.00568	0.0119	CbGbCtD
Probenecid—SLC22A7—Methotrexate—breast cancer	0.00545	0.0114	CbGbCtD
Probenecid—ABCC4—Methotrexate—breast cancer	0.00532	0.0111	CbGbCtD
Probenecid—ABCC2—Vinblastine—breast cancer	0.00532	0.0111	CbGbCtD
Probenecid—CYP3A4—Letrozole—breast cancer	0.00511	0.0107	CbGbCtD
Probenecid—ABCB1—Lapatinib—breast cancer	0.00507	0.0106	CbGbCtD
Probenecid—CYP3A4—Anastrozole—breast cancer	0.00456	0.00953	CbGbCtD
Probenecid—ABCC1—Doxorubicin—breast cancer	0.00442	0.00924	CbGbCtD
Probenecid—ABCC2—Docetaxel—breast cancer	0.00438	0.00917	CbGbCtD
Probenecid—ABCC1—Methotrexate—breast cancer	0.00428	0.00895	CbGbCtD
Probenecid—CYP3A4—Toremifene—breast cancer	0.00417	0.00871	CbGbCtD
Probenecid—CYP3A4—Fulvestrant—breast cancer	0.00387	0.0081	CbGbCtD
Probenecid—SLCO1A2—Methotrexate—breast cancer	0.00382	0.00799	CbGbCtD
Probenecid—CYP2C8—Tamoxifen—breast cancer	0.00375	0.00785	CbGbCtD
Probenecid—ALB—Irinotecan—breast cancer	0.00373	0.0078	CbGbCtD
Probenecid—ALB—Fluorouracil—breast cancer	0.00358	0.00748	CbGbCtD
Probenecid—CYP3A4—Thiotepa—breast cancer	0.00345	0.00722	CbGbCtD
Probenecid—SLC22A8—Methotrexate—breast cancer	0.00333	0.00696	CbGbCtD
Probenecid—ABCC2—Doxorubicin—breast cancer	0.00327	0.00684	CbGbCtD
Probenecid—CYP2C9—Capecitabine—breast cancer	0.00325	0.0068	CbGbCtD
Probenecid—ABCC2—Methotrexate—breast cancer	0.00317	0.00662	CbGbCtD
Probenecid—CYP3A4—Ixabepilone—breast cancer	0.00316	0.0066	CbGbCtD
Probenecid—CYP2C19—Tamoxifen—breast cancer	0.00315	0.00658	CbGbCtD
Probenecid—CYP3A4—Lapatinib—breast cancer	0.00304	0.00636	CbGbCtD
Probenecid—CYP2C8—Paclitaxel—breast cancer	0.00292	0.00611	CbGbCtD
Probenecid—ABCB1—Vinorelbine—breast cancer	0.00281	0.00589	CbGbCtD
Probenecid—CYP2C8—Fluorouracil—breast cancer	0.00277	0.00578	CbGbCtD
Probenecid—CYP2C9—Tamoxifen—breast cancer	0.00262	0.00547	CbGbCtD
Probenecid—ABCB1—Tamoxifen—breast cancer	0.00254	0.00531	CbGbCtD
Probenecid—ABCB1—Mitoxantrone—breast cancer	0.00248	0.00518	CbGbCtD
Probenecid—SLC22A6—Methotrexate—breast cancer	0.00232	0.00485	CbGbCtD
Probenecid—CYP3A4—Raloxifene—breast cancer	0.0023	0.00482	CbGbCtD
Probenecid—ABCB1—Gemcitabine—breast cancer	0.00219	0.00458	CbGbCtD
Probenecid—ABCC11—mammary gland—breast cancer	0.00213	0.0486	CbGeAlD
Probenecid—CYP2C9—Paclitaxel—breast cancer	0.00204	0.00426	CbGbCtD
Probenecid—ABCB1—Paclitaxel—breast cancer	0.00198	0.00414	CbGbCtD
Probenecid—ALB—Methotrexate—breast cancer	0.00197	0.00413	CbGbCtD
Probenecid—ABCB1—Irinotecan—breast cancer	0.00195	0.00408	CbGbCtD
Probenecid—CYP2C9—Fluorouracil—breast cancer	0.00193	0.00403	CbGbCtD
Probenecid—ABCB1—Vinblastine—breast cancer	0.00173	0.00363	CbGbCtD
Probenecid—CYP3A4—Vinorelbine—breast cancer	0.00169	0.00353	CbGbCtD
Probenecid—CYP3A4—Tamoxifen—breast cancer	0.00152	0.00318	CbGbCtD
Probenecid—CYP3A4—Mitoxantrone—breast cancer	0.00148	0.0031	CbGbCtD
Probenecid—ABCC11—embryo—breast cancer	0.00146	0.0331	CbGeAlD
Probenecid—ABCB1—Docetaxel—breast cancer	0.00143	0.00299	CbGbCtD
Probenecid—CYP3A4—Paclitaxel—breast cancer	0.00118	0.00248	CbGbCtD
Probenecid—CYP3A4—Irinotecan—breast cancer	0.00117	0.00244	CbGbCtD
Probenecid—PANX1—endometrium—breast cancer	0.00111	0.0253	CbGeAlD
Probenecid—ABCB1—Doxorubicin—breast cancer	0.00107	0.00223	CbGbCtD
Probenecid—CYP3A4—Vinblastine—breast cancer	0.00104	0.00217	CbGbCtD
Probenecid—ABCB1—Methotrexate—breast cancer	0.00103	0.00216	CbGbCtD
Probenecid—PANX1—uterus—breast cancer	0.00102	0.0233	CbGeAlD
Probenecid—PANX1—pituitary gland—breast cancer	0.00101	0.0229	CbGeAlD
Probenecid—PANX1—adipose tissue—breast cancer	0.001	0.0228	CbGeAlD
Probenecid—SLC16A7—nipple—breast cancer	0.000985	0.0224	CbGeAlD
Probenecid—PANX1—adrenal gland—breast cancer	0.000899	0.0205	CbGeAlD
Probenecid—ABCC11—female reproductive system—breast cancer	0.000883	0.0201	CbGeAlD
Probenecid—CYP3A4—Docetaxel—breast cancer	0.000856	0.00179	CbGbCtD
Probenecid—PANX1—female gonad—breast cancer	0.000838	0.0191	CbGeAlD
Probenecid—SLC2A9—female reproductive system—breast cancer	0.000835	0.019	CbGeAlD
Probenecid—ABCC5—mammary gland—breast cancer	0.000833	0.019	CbGeAlD
Probenecid—SLC2A9—adrenal gland—breast cancer	0.000815	0.0185	CbGeAlD
Probenecid—ABCC11—female gonad—breast cancer	0.000804	0.0183	CbGeAlD
Probenecid—SLC2A9—female gonad—breast cancer	0.00076	0.0173	CbGeAlD
Probenecid—ABCC11—endocrine gland—breast cancer	0.000747	0.017	CbGeAlD
Probenecid—SLC2A9—endocrine gland—breast cancer	0.000707	0.0161	CbGeAlD
Probenecid—CYP3A4—Doxorubicin—breast cancer	0.000638	0.00134	CbGbCtD
Probenecid—ALB—mammary gland—breast cancer	0.000597	0.0136	CbGeAlD
Probenecid—Procaine—SCN10A—breast cancer	0.000572	0.227	CrCbGaD
Probenecid—ABCC6—adipose tissue—breast cancer	0.000552	0.0126	CbGeAlD
Probenecid—SLC16A7—uterus—breast cancer	0.000548	0.0125	CbGeAlD
Probenecid—PANX1—lymph node—breast cancer	0.000539	0.0123	CbGeAlD
Probenecid—SLC16A7—pituitary gland—breast cancer	0.000538	0.0122	CbGeAlD
Probenecid—SLC16A7—adipose tissue—breast cancer	0.000536	0.0122	CbGeAlD
Probenecid—SLC16A7—female reproductive system—breast cancer	0.000493	0.0112	CbGeAlD
Probenecid—SLC2A9—lymph node—breast cancer	0.000489	0.0111	CbGeAlD
Probenecid—SLC16A7—adrenal gland—breast cancer	0.000481	0.0109	CbGeAlD
Probenecid—Procainamide—DNMT1—breast cancer	0.000476	0.189	CrCbGaD
Probenecid—SLCO1C1—pituitary gland—breast cancer	0.000473	0.0108	CbGeAlD
Probenecid—SLCO1C1—adipose tissue—breast cancer	0.000471	0.0107	CbGeAlD
Probenecid—SLC10A1—female reproductive system—breast cancer	0.00046	0.0105	CbGeAlD
Probenecid—SLC22A5—mammary gland—breast cancer	0.000433	0.00986	CbGeAlD
Probenecid—ABCC6—endocrine gland—breast cancer	0.000429	0.00977	CbGeAlD
Probenecid—SLC16A1—epithelium—breast cancer	0.000422	0.00961	CbGeAlD
Probenecid—SLC22A11—female reproductive system—breast cancer	0.00042	0.00956	CbGeAlD
Probenecid—CYP2C8—mammary gland—breast cancer	0.000419	0.00954	CbGeAlD
Probenecid—SLC16A7—endocrine gland—breast cancer	0.000417	0.00949	CbGeAlD
Probenecid—ABCC1—nipple—breast cancer	0.000407	0.00927	CbGeAlD
Probenecid—SLC10A1—endocrine gland—breast cancer	0.000389	0.00886	CbGeAlD
Probenecid—SLC16A1—endometrium—breast cancer	0.000379	0.00861	CbGeAlD
Probenecid—ABCC5—pituitary gland—breast cancer	0.000377	0.00857	CbGeAlD
Probenecid—ABCC5—adipose tissue—breast cancer	0.000375	0.00853	CbGeAlD
Probenecid—CYP2C9—mammary gland—breast cancer	0.000373	0.00848	CbGeAlD
Probenecid—SLCO1C1—endocrine gland—breast cancer	0.000366	0.00833	CbGeAlD
Probenecid—SLC22A5—nipple—breast cancer	0.000358	0.00815	CbGeAlD
Probenecid—SLC22A11—endocrine gland—breast cancer	0.000356	0.00809	CbGeAlD
Probenecid—SLC16A1—uterus—breast cancer	0.000349	0.00794	CbGeAlD
Probenecid—SLC22A7—endocrine gland—breast cancer	0.000347	0.0079	CbGeAlD
Probenecid—SLC16A1—pituitary gland—breast cancer	0.000343	0.0078	CbGeAlD
Probenecid—SLC16A1—adipose tissue—breast cancer	0.000341	0.00776	CbGeAlD
Probenecid—ABCC5—adrenal gland—breast cancer	0.000336	0.00765	CbGeAlD
Probenecid—ABCC5—bone marrow—breast cancer	0.000326	0.00741	CbGeAlD
Probenecid—Procaine—BCHE—breast cancer	0.00032	0.127	CrCbGaD
Probenecid—ABCC3—adipose tissue—breast cancer	0.000315	0.00717	CbGeAlD
Probenecid—ABCC5—female gonad—breast cancer	0.000314	0.00714	CbGeAlD
Probenecid—SLC16A1—female reproductive system—breast cancer	0.000314	0.00714	CbGeAlD
Probenecid—SLC16A1—adrenal gland—breast cancer	0.000306	0.00696	CbGeAlD
Probenecid—Procainamide—SCN10A—breast cancer	0.000296	0.118	CrCbGaD
Probenecid—ABCC3—female reproductive system—breast cancer	0.00029	0.00659	CbGeAlD
Probenecid—SLC16A7—lymph node—breast cancer	0.000288	0.00656	CbGeAlD
Probenecid—SLC16A1—female gonad—breast cancer	0.000285	0.00649	CbGeAlD
Probenecid—ABCC3—adrenal gland—breast cancer	0.000283	0.00643	CbGeAlD
Probenecid—Procainamide—ACHE—breast cancer	0.000282	0.112	CrCbGaD
Probenecid—SLC22A1—adipose tissue—breast cancer	0.000281	0.00638	CbGeAlD
Probenecid—ABCC4—uterus—breast cancer	0.000266	0.00605	CbGeAlD
Probenecid—SLC16A1—endocrine gland—breast cancer	0.000265	0.00604	CbGeAlD
Probenecid—ABCC3—female gonad—breast cancer	0.000263	0.00599	CbGeAlD
Probenecid—ABCC4—adipose tissue—breast cancer	0.00026	0.00592	CbGeAlD
Probenecid—SLCO1C1—lymph node—breast cancer	0.000253	0.00576	CbGeAlD
Probenecid—ABCC1—endometrium—breast cancer	0.000246	0.0056	CbGeAlD
Probenecid—ABCC3—endocrine gland—breast cancer	0.000245	0.00557	CbGeAlD
Probenecid—ALB—adrenal gland—breast cancer	0.000241	0.00548	CbGeAlD
Probenecid—ABCC4—female reproductive system—breast cancer	0.000239	0.00544	CbGeAlD
Probenecid—ABCC4—adrenal gland—breast cancer	0.000233	0.00531	CbGeAlD
Probenecid—ABCC2—female reproductive system—breast cancer	0.000231	0.00526	CbGeAlD
Probenecid—SLC22A5—skin of body—breast cancer	0.000229	0.00522	CbGeAlD
Probenecid—ABCC1—uterus—breast cancer	0.000227	0.00516	CbGeAlD
Probenecid—ABCC2—adrenal gland—breast cancer	0.000226	0.00514	CbGeAlD
Probenecid—ABCC4—bone marrow—breast cancer	0.000226	0.00513	CbGeAlD
Probenecid—ABCC1—pituitary gland—breast cancer	0.000223	0.00506	CbGeAlD
Probenecid—ABCC1—adipose tissue—breast cancer	0.000222	0.00504	CbGeAlD
Probenecid—SLC22A1—endocrine gland—breast cancer	0.000218	0.00497	CbGeAlD
Probenecid—ABCC4—female gonad—breast cancer	0.000217	0.00495	CbGeAlD
Probenecid—SLC22A5—endometrium—breast cancer	0.000216	0.00492	CbGeAlD
Probenecid—Chlorpropamide—PTGS1—breast cancer	0.00021	0.0836	CrCbGaD
Probenecid—SLCO1A2—endocrine gland—breast cancer	0.00021	0.00478	CbGeAlD
Probenecid—CYP2C8—endometrium—breast cancer	0.000209	0.00477	CbGeAlD
Probenecid—ABCC4—endocrine gland—breast cancer	0.000202	0.0046	CbGeAlD
Probenecid—ABCC5—lymph node—breast cancer	0.000202	0.00459	CbGeAlD
Probenecid—ABCC1—adrenal gland—breast cancer	0.000199	0.00452	CbGeAlD
Probenecid—SLC22A5—pituitary gland—breast cancer	0.000196	0.00445	CbGeAlD
Probenecid—ABCC2—endocrine gland—breast cancer	0.000196	0.00445	CbGeAlD
Probenecid—SLC22A5—adipose tissue—breast cancer	0.000195	0.00444	CbGeAlD
Probenecid—CYP2C8—pituitary gland—breast cancer	0.00019	0.00431	CbGeAlD
Probenecid—ABCC1—female gonad—breast cancer	0.000185	0.00422	CbGeAlD
Probenecid—SLC16A1—lymph node—breast cancer	0.000184	0.00417	CbGeAlD
Probenecid—SLC22A5—female reproductive system—breast cancer	0.000179	0.00408	CbGeAlD
Probenecid—SLC22A5—adrenal gland—breast cancer	0.000175	0.00398	CbGeAlD
Probenecid—Alopecia—Mitoxantrone—breast cancer	0.000174	0.00215	CcSEcCtD
Probenecid—CYP2C8—female reproductive system—breast cancer	0.000174	0.00395	CbGeAlD
Probenecid—Dermatitis—Raloxifene—breast cancer	0.000173	0.00214	CcSEcCtD
Probenecid—Dermatitis—Idarubicin—breast cancer	0.000173	0.00214	CcSEcCtD
Probenecid—Decreased appetite—Tamoxifen—breast cancer	0.000173	0.00213	CcSEcCtD
Probenecid—Headache—Idarubicin—breast cancer	0.000172	0.00213	CcSEcCtD
Probenecid—Headache—Raloxifene—breast cancer	0.000172	0.00213	CcSEcCtD
Probenecid—Nausea—Letrozole—breast cancer	0.000172	0.00213	CcSEcCtD
Probenecid—Nausea—Anastrozole—breast cancer	0.000172	0.00213	CcSEcCtD
Probenecid—Aplastic anaemia—Epirubicin—breast cancer	0.000172	0.00212	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Capecitabine—breast cancer	0.000172	0.00212	CcSEcCtD
Probenecid—Haematuria—Paclitaxel—breast cancer	0.000171	0.00211	CcSEcCtD
Probenecid—Anaphylactic shock—Vinorelbine—breast cancer	0.00017	0.00209	CcSEcCtD
Probenecid—Pain—Tamoxifen—breast cancer	0.00017	0.00209	CcSEcCtD
Probenecid—Alopecia—Gemcitabine—breast cancer	0.00017	0.00209	CcSEcCtD
Probenecid—ABCC3—lymph node—breast cancer	0.000169	0.00385	CbGeAlD
Probenecid—Decreased appetite—Melphalan—breast cancer	0.000169	0.00208	CcSEcCtD
Probenecid—CYP2C19—endocrine gland—breast cancer	0.000168	0.00383	CbGeAlD
Probenecid—Alopecia—Fluorouracil—breast cancer	0.000167	0.00206	CcSEcCtD
Probenecid—Pain—Melphalan—breast cancer	0.000166	0.00205	CcSEcCtD
Probenecid—Procainamide—BCHE—breast cancer	0.000166	0.0659	CrCbGaD
Probenecid—Decreased appetite—Goserelin—breast cancer	0.000165	0.00203	CcSEcCtD
Probenecid—Hypersensitivity—Chlorambucil—breast cancer	0.000164	0.00203	CcSEcCtD
Probenecid—Nausea—Idarubicin—breast cancer	0.000164	0.00202	CcSEcCtD
Probenecid—Nausea—Raloxifene—breast cancer	0.000164	0.00202	CcSEcCtD
Probenecid—SLC22A5—female gonad—breast cancer	0.000163	0.00371	CbGeAlD
Probenecid—Pain—Goserelin—breast cancer	0.000162	0.002	CcSEcCtD
Probenecid—Anorexia—Vinorelbine—breast cancer	0.000162	0.002	CcSEcCtD
Probenecid—Aplastic anaemia—Doxorubicin—breast cancer	0.000159	0.00196	CcSEcCtD
Probenecid—Anaemia—Irinotecan—breast cancer	0.000159	0.00196	CcSEcCtD
Probenecid—Anaemia—Mitoxantrone—breast cancer	0.000159	0.00196	CcSEcCtD
Probenecid—Pruritus—Chlorambucil—breast cancer	0.000158	0.00195	CcSEcCtD
Probenecid—Urticaria—Tamoxifen—breast cancer	0.000158	0.00194	CcSEcCtD
Probenecid—Anorexia—Thiotepa—breast cancer	0.000155	0.00191	CcSEcCtD
Probenecid—Anaemia—Gemcitabine—breast cancer	0.000155	0.00191	CcSEcCtD
Probenecid—Urticaria—Melphalan—breast cancer	0.000154	0.0019	CcSEcCtD
Probenecid—CYP2C9—female reproductive system—breast cancer	0.000154	0.00351	CbGeAlD
Probenecid—Leukopenia—Mitoxantrone—breast cancer	0.000154	0.00189	CcSEcCtD
Probenecid—Leukopenia—Irinotecan—breast cancer	0.000154	0.00189	CcSEcCtD
Probenecid—Erythema multiforme—Paclitaxel—breast cancer	0.000152	0.00187	CcSEcCtD
Probenecid—Anaemia—Fluorouracil—breast cancer	0.000152	0.00187	CcSEcCtD
Probenecid—Urticaria—Goserelin—breast cancer	0.000151	0.00186	CcSEcCtD
Probenecid—Hypersensitivity—Vinblastine—breast cancer	0.000151	0.00186	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Docetaxel—breast cancer	0.00015	0.00186	CcSEcCtD
Probenecid—Body temperature increased—Goserelin—breast cancer	0.00015	0.00185	CcSEcCtD
Probenecid—Leukopenia—Gemcitabine—breast cancer	0.00015	0.00185	CcSEcCtD
Probenecid—Flushing—Paclitaxel—breast cancer	0.000149	0.00184	CcSEcCtD
Probenecid—Decreased appetite—Vinorelbine—breast cancer	0.000148	0.00182	CcSEcCtD
Probenecid—Leukopenia—Fluorouracil—breast cancer	0.000147	0.00181	CcSEcCtD
Probenecid—CYP2C8—endocrine gland—breast cancer	0.000147	0.00334	CbGeAlD
Probenecid—Hypersensitivity—Tamoxifen—breast cancer	0.000146	0.0018	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Capecitabine—breast cancer	0.000146	0.0018	CcSEcCtD
Probenecid—Pain—Vinorelbine—breast cancer	0.000145	0.00179	CcSEcCtD
Probenecid—ALB—lymph node—breast cancer	0.000144	0.00329	CbGeAlD
Probenecid—Hypersensitivity—Melphalan—breast cancer	0.000143	0.00177	CcSEcCtD
Probenecid—Alopecia—Paclitaxel—breast cancer	0.000142	0.00175	CcSEcCtD
Probenecid—Vomiting—Chlorambucil—breast cancer	0.000142	0.00175	CcSEcCtD
Probenecid—Decreased appetite—Thiotepa—breast cancer	0.000141	0.00174	CcSEcCtD
Probenecid—Pruritus—Tamoxifen—breast cancer	0.00014	0.00173	CcSEcCtD
Probenecid—Haematuria—Capecitabine—breast cancer	0.00014	0.00173	CcSEcCtD
Probenecid—Anaphylactic shock—Mitoxantrone—breast cancer	0.00014	0.00173	CcSEcCtD
Probenecid—Anaphylactic shock—Irinotecan—breast cancer	0.00014	0.00173	CcSEcCtD
Probenecid—ABCC4—lymph node—breast cancer	0.00014	0.00318	CbGeAlD
Probenecid—Hypersensitivity—Goserelin—breast cancer	0.00014	0.00172	CcSEcCtD
Probenecid—Pain—Thiotepa—breast cancer	0.000139	0.00171	CcSEcCtD
Probenecid—Pruritus—Melphalan—breast cancer	0.000138	0.0017	CcSEcCtD
Probenecid—ABCB1—embryo—breast cancer	0.000137	0.00312	CbGeAlD
Probenecid—Anaphylactic shock—Gemcitabine—breast cancer	0.000136	0.00168	CcSEcCtD
Probenecid—ABCC2—lymph node—breast cancer	0.000135	0.00308	CbGeAlD
Probenecid—Dizziness—Vinblastine—breast cancer	0.000135	0.00167	CcSEcCtD
Probenecid—Urticaria—Vinorelbine—breast cancer	0.000135	0.00166	CcSEcCtD
Probenecid—Body temperature increased—Vinorelbine—breast cancer	0.000134	0.00166	CcSEcCtD
Probenecid—Pruritus—Goserelin—breast cancer	0.000134	0.00165	CcSEcCtD
Probenecid—Anaphylactic shock—Fluorouracil—breast cancer	0.000134	0.00165	CcSEcCtD
Probenecid—Anorexia—Mitoxantrone—breast cancer	0.000134	0.00165	CcSEcCtD
Probenecid—Anorexia—Irinotecan—breast cancer	0.000134	0.00165	CcSEcCtD
Probenecid—Nausea—Chlorambucil—breast cancer	0.000132	0.00163	CcSEcCtD
Probenecid—Dizziness—Tamoxifen—breast cancer	0.000131	0.00162	CcSEcCtD
Probenecid—CYP2C9—endocrine gland—breast cancer	0.00013	0.00297	CbGeAlD
Probenecid—Anorexia—Gemcitabine—breast cancer	0.00013	0.0016	CcSEcCtD
Probenecid—Vomiting—Vinblastine—breast cancer	0.00013	0.0016	CcSEcCtD
Probenecid—Anaemia—Paclitaxel—breast cancer	0.000129	0.0016	CcSEcCtD
Probenecid—Erythema multiforme—Docetaxel—breast cancer	0.000129	0.00159	CcSEcCtD
Probenecid—Urticaria—Thiotepa—breast cancer	0.000129	0.00159	CcSEcCtD
Probenecid—Body temperature increased—Thiotepa—breast cancer	0.000128	0.00158	CcSEcCtD
Probenecid—Headache—Vinblastine—breast cancer	0.000128	0.00158	CcSEcCtD
Probenecid—Anorexia—Fluorouracil—breast cancer	0.000128	0.00158	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Methotrexate—breast cancer	0.000128	0.00158	CcSEcCtD
Probenecid—Flushing—Docetaxel—breast cancer	0.000126	0.00156	CcSEcCtD
Probenecid—Vomiting—Tamoxifen—breast cancer	0.000126	0.00156	CcSEcCtD
Probenecid—Dizziness—Goserelin—breast cancer	0.000125	0.00155	CcSEcCtD
Probenecid—Leukopenia—Paclitaxel—breast cancer	0.000125	0.00155	CcSEcCtD
Probenecid—Hypersensitivity—Vinorelbine—breast cancer	0.000125	0.00154	CcSEcCtD
Probenecid—Dermatitis—Tamoxifen—breast cancer	0.000125	0.00154	CcSEcCtD
Probenecid—Erythema multiforme—Capecitabine—breast cancer	0.000125	0.00154	CcSEcCtD
Probenecid—Headache—Tamoxifen—breast cancer	0.000124	0.00153	CcSEcCtD
Probenecid—Vomiting—Melphalan—breast cancer	0.000124	0.00152	CcSEcCtD
Probenecid—Flushing—Capecitabine—breast cancer	0.000122	0.00151	CcSEcCtD
Probenecid—Dermatitis—Melphalan—breast cancer	0.000122	0.00151	CcSEcCtD
Probenecid—Decreased appetite—Irinotecan—breast cancer	0.000122	0.0015	CcSEcCtD
Probenecid—Decreased appetite—Mitoxantrone—breast cancer	0.000122	0.0015	CcSEcCtD
Probenecid—Nausea—Vinblastine—breast cancer	0.000121	0.0015	CcSEcCtD
Probenecid—Vomiting—Goserelin—breast cancer	0.000121	0.00149	CcSEcCtD
Probenecid—Alopecia—Docetaxel—breast cancer	0.00012	0.00149	CcSEcCtD
Probenecid—Pruritus—Vinorelbine—breast cancer	0.00012	0.00148	CcSEcCtD
Probenecid—Pain—Mitoxantrone—breast cancer	0.00012	0.00148	CcSEcCtD
Probenecid—Pain—Irinotecan—breast cancer	0.00012	0.00148	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Epirubicin—breast cancer	0.00012	0.00148	CcSEcCtD
Probenecid—Hypersensitivity—Thiotepa—breast cancer	0.000119	0.00147	CcSEcCtD
Probenecid—Dermatitis—Goserelin—breast cancer	0.000119	0.00147	CcSEcCtD
Probenecid—ABCC1—lymph node—breast cancer	0.000119	0.00271	CbGeAlD
Probenecid—Headache—Goserelin—breast cancer	0.000119	0.00146	CcSEcCtD
Probenecid—Decreased appetite—Gemcitabine—breast cancer	0.000119	0.00146	CcSEcCtD
Probenecid—Nausea—Tamoxifen—breast cancer	0.000118	0.00145	CcSEcCtD
Probenecid—CYP3A4—female reproductive system—breast cancer	0.000118	0.00267	CbGeAlD
Probenecid—Pain—Gemcitabine—breast cancer	0.000117	0.00144	CcSEcCtD
Probenecid—Decreased appetite—Fluorouracil—breast cancer	0.000117	0.00144	CcSEcCtD
Probenecid—Alopecia—Capecitabine—breast cancer	0.000117	0.00144	CcSEcCtD
Probenecid—Nausea—Melphalan—breast cancer	0.000115	0.00142	CcSEcCtD
Probenecid—Pruritus—Thiotepa—breast cancer	0.000115	0.00142	CcSEcCtD
Probenecid—Pain—Fluorouracil—breast cancer	0.000115	0.00141	CcSEcCtD
Probenecid—Anaphylactic shock—Paclitaxel—breast cancer	0.000114	0.00141	CcSEcCtD
Probenecid—Nausea—Goserelin—breast cancer	0.000113	0.00139	CcSEcCtD
Probenecid—Dizziness—Vinorelbine—breast cancer	0.000112	0.00138	CcSEcCtD
Probenecid—ABCB1—epithelium—breast cancer	0.000112	0.00255	CbGeAlD
Probenecid—Urticaria—Mitoxantrone—breast cancer	0.000111	0.00137	CcSEcCtD
Probenecid—Body temperature increased—Mitoxantrone—breast cancer	0.000111	0.00137	CcSEcCtD
Probenecid—Body temperature increased—Irinotecan—breast cancer	0.000111	0.00137	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000111	0.00137	CcSEcCtD
Probenecid—Anaemia—Docetaxel—breast cancer	0.00011	0.00135	CcSEcCtD
Probenecid—Anorexia—Paclitaxel—breast cancer	0.000109	0.00134	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000108	0.00134	CcSEcCtD
Probenecid—Vomiting—Vinorelbine—breast cancer	0.000108	0.00133	CcSEcCtD
Probenecid—Body temperature increased—Gemcitabine—breast cancer	0.000108	0.00133	CcSEcCtD
Probenecid—Dizziness—Thiotepa—breast cancer	0.000107	0.00132	CcSEcCtD
Probenecid—Dermatitis—Vinorelbine—breast cancer	0.000107	0.00132	CcSEcCtD
Probenecid—Urticaria—Fluorouracil—breast cancer	0.000107	0.00131	CcSEcCtD
Probenecid—Headache—Vinorelbine—breast cancer	0.000106	0.00131	CcSEcCtD
Probenecid—Leukopenia—Docetaxel—breast cancer	0.000106	0.00131	CcSEcCtD
Probenecid—Anaemia—Capecitabine—breast cancer	0.000106	0.00131	CcSEcCtD
Probenecid—Pollakiuria—Epirubicin—breast cancer	0.000106	0.00131	CcSEcCtD
Probenecid—Body temperature increased—Fluorouracil—breast cancer	0.000106	0.00131	CcSEcCtD
Probenecid—SLC22A5—lymph node—breast cancer	0.000105	0.00239	CbGeAlD
Probenecid—Haematuria—Methotrexate—breast cancer	0.000104	0.00129	CcSEcCtD
Probenecid—Hypersensitivity—Irinotecan—breast cancer	0.000103	0.00127	CcSEcCtD
Probenecid—Hypersensitivity—Mitoxantrone—breast cancer	0.000103	0.00127	CcSEcCtD
Probenecid—Vomiting—Thiotepa—breast cancer	0.000103	0.00127	CcSEcCtD
Probenecid—Leukopenia—Capecitabine—breast cancer	0.000103	0.00127	CcSEcCtD
Probenecid—Chlorpropamide—ABCB1—breast cancer	0.000102	0.0407	CrCbGaD
Probenecid—Dermatitis—Thiotepa—breast cancer	0.000102	0.00126	CcSEcCtD
Probenecid—Headache—Thiotepa—breast cancer	0.000102	0.00125	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000102	0.00125	CcSEcCtD
Probenecid—Nausea—Vinorelbine—breast cancer	0.000101	0.00124	CcSEcCtD
Probenecid—ABCB1—endometrium—breast cancer	0.0001	0.00228	CbGeAlD
Probenecid—CYP3A4—endocrine gland—breast cancer	9.95e-05	0.00226	CbGeAlD
Probenecid—Decreased appetite—Paclitaxel—breast cancer	9.93e-05	0.00122	CcSEcCtD
Probenecid—Hypersensitivity—Fluorouracil—breast cancer	9.88e-05	0.00122	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—breast cancer	9.82e-05	0.00121	CcSEcCtD
Probenecid—Pain—Paclitaxel—breast cancer	9.77e-05	0.0012	CcSEcCtD
Probenecid—Haematuria—Epirubicin—breast cancer	9.76e-05	0.0012	CcSEcCtD
Probenecid—Anaphylactic shock—Docetaxel—breast cancer	9.68e-05	0.00119	CcSEcCtD
Probenecid—Pruritus—Gemcitabine—breast cancer	9.65e-05	0.00119	CcSEcCtD
Probenecid—Nausea—Thiotepa—breast cancer	9.63e-05	0.00119	CcSEcCtD
Probenecid—Pruritus—Fluorouracil—breast cancer	9.49e-05	0.00117	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—breast cancer	9.39e-05	0.00116	CcSEcCtD
Probenecid—Erythema multiforme—Methotrexate—breast cancer	9.29e-05	0.00115	CcSEcCtD
Probenecid—Dizziness—Irinotecan—breast cancer	9.26e-05	0.00114	CcSEcCtD
Probenecid—ABCB1—uterus—breast cancer	9.25e-05	0.00211	CbGeAlD
Probenecid—Anorexia—Docetaxel—breast cancer	9.23e-05	0.00114	CcSEcCtD
Probenecid—Procainamide—CYP2D6—breast cancer	9.1e-05	0.0362	CrCbGaD
Probenecid—ABCB1—pituitary gland—breast cancer	9.09e-05	0.00207	CbGeAlD
Probenecid—Urticaria—Paclitaxel—breast cancer	9.07e-05	0.00112	CcSEcCtD
Probenecid—ABCB1—adipose tissue—breast cancer	9.05e-05	0.00206	CbGeAlD
Probenecid—Haematuria—Doxorubicin—breast cancer	9.03e-05	0.00111	CcSEcCtD
Probenecid—Body temperature increased—Paclitaxel—breast cancer	9.03e-05	0.00111	CcSEcCtD
Probenecid—Anorexia—Capecitabine—breast cancer	8.93e-05	0.0011	CcSEcCtD
Probenecid—Vomiting—Mitoxantrone—breast cancer	8.9e-05	0.0011	CcSEcCtD
Probenecid—Vomiting—Irinotecan—breast cancer	8.9e-05	0.0011	CcSEcCtD
Probenecid—Dizziness—Fluorouracil—breast cancer	8.87e-05	0.00109	CcSEcCtD
Probenecid—Dermatitis—Irinotecan—breast cancer	8.82e-05	0.00109	CcSEcCtD
Probenecid—Dermatitis—Mitoxantrone—breast cancer	8.82e-05	0.00109	CcSEcCtD
Probenecid—Headache—Irinotecan—breast cancer	8.77e-05	0.00108	CcSEcCtD
Probenecid—Headache—Mitoxantrone—breast cancer	8.77e-05	0.00108	CcSEcCtD
Probenecid—Erythema multiforme—Epirubicin—breast cancer	8.69e-05	0.00107	CcSEcCtD
Probenecid—Alopecia—Methotrexate—breast cancer	8.68e-05	0.00107	CcSEcCtD
Probenecid—Vomiting—Gemcitabine—breast cancer	8.67e-05	0.00107	CcSEcCtD
Probenecid—Dermatitis—Gemcitabine—breast cancer	8.59e-05	0.00106	CcSEcCtD
Probenecid—Headache—Gemcitabine—breast cancer	8.55e-05	0.00105	CcSEcCtD
Probenecid—Flushing—Epirubicin—breast cancer	8.53e-05	0.00105	CcSEcCtD
Probenecid—Vomiting—Fluorouracil—breast cancer	8.53e-05	0.00105	CcSEcCtD
Probenecid—Dermatitis—Fluorouracil—breast cancer	8.45e-05	0.00104	CcSEcCtD
Probenecid—Decreased appetite—Docetaxel—breast cancer	8.42e-05	0.00104	CcSEcCtD
Probenecid—Hypersensitivity—Paclitaxel—breast cancer	8.42e-05	0.00104	CcSEcCtD
Probenecid—Headache—Fluorouracil—breast cancer	8.4e-05	0.00104	CcSEcCtD
Probenecid—ABCB1—female reproductive system—breast cancer	8.32e-05	0.00189	CbGeAlD
Probenecid—Nausea—Mitoxantrone—breast cancer	8.32e-05	0.00103	CcSEcCtD
Probenecid—Nausea—Irinotecan—breast cancer	8.32e-05	0.00103	CcSEcCtD
Probenecid—Pain—Docetaxel—breast cancer	8.28e-05	0.00102	CcSEcCtD
Probenecid—Decreased appetite—Capecitabine—breast cancer	8.15e-05	0.001	CcSEcCtD
Probenecid—Alopecia—Epirubicin—breast cancer	8.12e-05	0.001	CcSEcCtD
Probenecid—ABCB1—adrenal gland—breast cancer	8.12e-05	0.00185	CbGeAlD
Probenecid—Nausea—Gemcitabine—breast cancer	8.1e-05	0.000999	CcSEcCtD
Probenecid—Pruritus—Paclitaxel—breast cancer	8.08e-05	0.000997	CcSEcCtD
Probenecid—Erythema multiforme—Doxorubicin—breast cancer	8.04e-05	0.000992	CcSEcCtD
Probenecid—Pain—Capecitabine—breast cancer	8.02e-05	0.000989	CcSEcCtD
Probenecid—Nausea—Fluorouracil—breast cancer	7.97e-05	0.000983	CcSEcCtD
Probenecid—Anaemia—Methotrexate—breast cancer	7.9e-05	0.000975	CcSEcCtD
Probenecid—Flushing—Doxorubicin—breast cancer	7.89e-05	0.000973	CcSEcCtD
Probenecid—ABCB1—bone marrow—breast cancer	7.85e-05	0.00179	CbGeAlD
Probenecid—Body temperature increased—Docetaxel—breast cancer	7.65e-05	0.000944	CcSEcCtD
Probenecid—Leukopenia—Methotrexate—breast cancer	7.65e-05	0.000944	CcSEcCtD
Probenecid—ABCB1—female gonad—breast cancer	7.57e-05	0.00172	CbGeAlD
Probenecid—Dizziness—Paclitaxel—breast cancer	7.55e-05	0.000932	CcSEcCtD
Probenecid—Alopecia—Doxorubicin—breast cancer	7.52e-05	0.000927	CcSEcCtD
Probenecid—Urticaria—Capecitabine—breast cancer	7.45e-05	0.000918	CcSEcCtD
Probenecid—Body temperature increased—Capecitabine—breast cancer	7.41e-05	0.000914	CcSEcCtD
Probenecid—Anaemia—Epirubicin—breast cancer	7.4e-05	0.000912	CcSEcCtD
Probenecid—Vomiting—Paclitaxel—breast cancer	7.26e-05	0.000896	CcSEcCtD
Probenecid—Dermatitis—Paclitaxel—breast cancer	7.2e-05	0.000887	CcSEcCtD
Probenecid—Leukopenia—Epirubicin—breast cancer	7.16e-05	0.000883	CcSEcCtD
Probenecid—Headache—Paclitaxel—breast cancer	7.16e-05	0.000883	CcSEcCtD
Probenecid—Hypersensitivity—Docetaxel—breast cancer	7.13e-05	0.00088	CcSEcCtD
Probenecid—ABCB1—endocrine gland—breast cancer	7.04e-05	0.0016	CbGeAlD
Probenecid—Anaphylactic shock—Methotrexate—breast cancer	6.98e-05	0.000861	CcSEcCtD
Probenecid—Hypersensitivity—Capecitabine—breast cancer	6.91e-05	0.000852	CcSEcCtD
Probenecid—Pruritus—Docetaxel—breast cancer	6.85e-05	0.000845	CcSEcCtD
Probenecid—Anaemia—Doxorubicin—breast cancer	6.84e-05	0.000844	CcSEcCtD
Probenecid—Nausea—Paclitaxel—breast cancer	6.78e-05	0.000837	CcSEcCtD
Probenecid—Anorexia—Methotrexate—breast cancer	6.65e-05	0.00082	CcSEcCtD
Probenecid—Pruritus—Capecitabine—breast cancer	6.63e-05	0.000818	CcSEcCtD
Probenecid—Leukopenia—Doxorubicin—breast cancer	6.63e-05	0.000817	CcSEcCtD
Probenecid—Anaphylactic shock—Epirubicin—breast cancer	6.53e-05	0.000805	CcSEcCtD
Probenecid—Dizziness—Docetaxel—breast cancer	6.4e-05	0.00079	CcSEcCtD
Probenecid—Anorexia—Epirubicin—breast cancer	6.22e-05	0.000768	CcSEcCtD
Probenecid—Dizziness—Capecitabine—breast cancer	6.2e-05	0.000764	CcSEcCtD
Probenecid—Vomiting—Docetaxel—breast cancer	6.16e-05	0.000759	CcSEcCtD
Probenecid—Dermatitis—Docetaxel—breast cancer	6.1e-05	0.000752	CcSEcCtD
Probenecid—Decreased appetite—Methotrexate—breast cancer	6.07e-05	0.000748	CcSEcCtD
Probenecid—Headache—Docetaxel—breast cancer	6.07e-05	0.000748	CcSEcCtD
Probenecid—Anaphylactic shock—Doxorubicin—breast cancer	6.04e-05	0.000745	CcSEcCtD
Probenecid—Pain—Methotrexate—breast cancer	5.97e-05	0.000736	CcSEcCtD
Probenecid—Vomiting—Capecitabine—breast cancer	5.96e-05	0.000735	CcSEcCtD
Probenecid—Dermatitis—Capecitabine—breast cancer	5.9e-05	0.000728	CcSEcCtD
Probenecid—Headache—Capecitabine—breast cancer	5.87e-05	0.000724	CcSEcCtD
Probenecid—Anorexia—Doxorubicin—breast cancer	5.76e-05	0.00071	CcSEcCtD
Probenecid—Nausea—Docetaxel—breast cancer	5.75e-05	0.000709	CcSEcCtD
Probenecid—Decreased appetite—Epirubicin—breast cancer	5.68e-05	0.0007	CcSEcCtD
Probenecid—Pain—Epirubicin—breast cancer	5.58e-05	0.000689	CcSEcCtD
Probenecid—Nausea—Capecitabine—breast cancer	5.57e-05	0.000687	CcSEcCtD
Probenecid—Urticaria—Methotrexate—breast cancer	5.54e-05	0.000684	CcSEcCtD
Probenecid—Body temperature increased—Methotrexate—breast cancer	5.52e-05	0.00068	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—breast cancer	5.25e-05	0.000648	CcSEcCtD
Probenecid—Urticaria—Epirubicin—breast cancer	5.19e-05	0.00064	CcSEcCtD
Probenecid—Pain—Doxorubicin—breast cancer	5.17e-05	0.000637	CcSEcCtD
Probenecid—Body temperature increased—Epirubicin—breast cancer	5.16e-05	0.000637	CcSEcCtD
Probenecid—Hypersensitivity—Methotrexate—breast cancer	5.14e-05	0.000634	CcSEcCtD
Probenecid—Pruritus—Methotrexate—breast cancer	4.94e-05	0.000609	CcSEcCtD
Probenecid—ABCB1—lymph node—breast cancer	4.87e-05	0.00111	CbGeAlD
Probenecid—Hypersensitivity—Epirubicin—breast cancer	4.81e-05	0.000593	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—breast cancer	4.8e-05	0.000592	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—breast cancer	4.78e-05	0.000589	CcSEcCtD
Probenecid—Pruritus—Epirubicin—breast cancer	4.62e-05	0.00057	CcSEcCtD
Probenecid—Dizziness—Methotrexate—breast cancer	4.61e-05	0.000569	CcSEcCtD
Probenecid—Hypersensitivity—Doxorubicin—breast cancer	4.45e-05	0.000549	CcSEcCtD
Probenecid—Vomiting—Methotrexate—breast cancer	4.44e-05	0.000547	CcSEcCtD
Probenecid—Dermatitis—Methotrexate—breast cancer	4.4e-05	0.000542	CcSEcCtD
Probenecid—Headache—Methotrexate—breast cancer	4.37e-05	0.000539	CcSEcCtD
Probenecid—Dizziness—Epirubicin—breast cancer	4.32e-05	0.000533	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—breast cancer	4.27e-05	0.000527	CcSEcCtD
Probenecid—Vomiting—Epirubicin—breast cancer	4.15e-05	0.000512	CcSEcCtD
Probenecid—Nausea—Methotrexate—breast cancer	4.14e-05	0.000511	CcSEcCtD
Probenecid—Dermatitis—Epirubicin—breast cancer	4.11e-05	0.000507	CcSEcCtD
Probenecid—Headache—Epirubicin—breast cancer	4.09e-05	0.000505	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—breast cancer	4e-05	0.000493	CcSEcCtD
Probenecid—Nausea—Epirubicin—breast cancer	3.88e-05	0.000478	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—breast cancer	3.84e-05	0.000474	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—breast cancer	3.81e-05	0.000469	CcSEcCtD
Probenecid—Headache—Doxorubicin—breast cancer	3.79e-05	0.000467	CcSEcCtD
Probenecid—Nausea—Doxorubicin—breast cancer	3.59e-05	0.000443	CcSEcCtD
Probenecid—ABCB1—Metabolism—CYP3A4—breast cancer	1.34e-06	1.22e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.33e-06	1.21e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CG—breast cancer	1.33e-06	1.21e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CTNNB1—breast cancer	1.33e-06	1.21e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CA—breast cancer	1.33e-06	1.21e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC5A5—breast cancer	1.33e-06	1.21e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—IDH1—breast cancer	1.33e-06	1.2e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTA1—breast cancer	1.33e-06	1.2e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.33e-06	1.2e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—HSP90AA1—breast cancer	1.32e-06	1.2e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—COMT—breast cancer	1.32e-06	1.2e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP1B1—breast cancer	1.32e-06	1.19e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—breast cancer	1.31e-06	1.19e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTP1—breast cancer	1.31e-06	1.19e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—COMT—breast cancer	1.31e-06	1.19e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NAT2—breast cancer	1.31e-06	1.19e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.31e-06	1.19e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTP1—breast cancer	1.31e-06	1.19e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDKN1A—breast cancer	1.3e-06	1.18e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTEN—breast cancer	1.3e-06	1.18e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—HMOX1—breast cancer	1.3e-06	1.18e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—breast cancer	1.29e-06	1.18e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ITPR1—breast cancer	1.29e-06	1.17e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—HSP90AA1—breast cancer	1.29e-06	1.17e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—HMOX1—breast cancer	1.29e-06	1.17e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NCOA1—breast cancer	1.29e-06	1.17e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ITPR1—breast cancer	1.29e-06	1.17e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NQO1—breast cancer	1.28e-06	1.16e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC2A1—breast cancer	1.28e-06	1.16e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—STK11—breast cancer	1.27e-06	1.15e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP19A1—breast cancer	1.27e-06	1.15e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CB—breast cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CD—breast cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NCOA1—breast cancer	1.25e-06	1.14e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP3A4—breast cancer	1.25e-06	1.14e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTGS2—breast cancer	1.25e-06	1.13e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.24e-06	1.13e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MAPK3—breast cancer	1.24e-06	1.13e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ABCB1—breast cancer	1.24e-06	1.13e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ALB—breast cancer	1.24e-06	1.13e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP19A1—breast cancer	1.24e-06	1.12e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—STK11—breast cancer	1.24e-06	1.12e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ABCB1—breast cancer	1.24e-06	1.12e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CA—breast cancer	1.23e-06	1.12e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP1B1—breast cancer	1.23e-06	1.12e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—TYMS—breast cancer	1.22e-06	1.11e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—TYMS—breast cancer	1.21e-06	1.1e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTEN—breast cancer	1.21e-06	1.1e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTM1—breast cancer	1.21e-06	1.1e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PLA2G4A—breast cancer	1.21e-06	1.1e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NCOR1—breast cancer	1.21e-06	1.1e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TGFB1—breast cancer	1.21e-06	1.1e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.21e-06	1.09e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—SRC—breast cancer	1.2e-06	1.09e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTM1—breast cancer	1.2e-06	1.09e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PLA2G4A—breast cancer	1.2e-06	1.09e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—NCOR1—breast cancer	1.2e-06	1.09e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.19e-06	1.08e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—NOS3—breast cancer	1.19e-06	1.08e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—COMT—breast cancer	1.18e-06	1.07e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTP1—breast cancer	1.17e-06	1.06e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NCOA1—breast cancer	1.17e-06	1.06e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CD—breast cancer	1.17e-06	1.06e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—STAT3—breast cancer	1.16e-06	1.05e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—HMOX1—breast cancer	1.16e-06	1.05e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ALB—breast cancer	1.16e-06	1.05e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GPX1—breast cancer	1.16e-06	1.05e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP19A1—breast cancer	1.16e-06	1.05e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—STK11—breast cancer	1.16e-06	1.05e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ITPR1—breast cancer	1.15e-06	1.05e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MED12—breast cancer	1.15e-06	1.04e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—DPYD—breast cancer	1.15e-06	1.04e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—COMT—breast cancer	1.15e-06	1.04e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GPX1—breast cancer	1.15e-06	1.04e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTP1—breast cancer	1.14e-06	1.04e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP1A1—breast cancer	1.14e-06	1.04e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP1A1—breast cancer	1.14e-06	1.03e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ERCC2—breast cancer	1.13e-06	1.03e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALDOA—breast cancer	1.13e-06	1.03e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—HMOX1—breast cancer	1.13e-06	1.02e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ERCC2—breast cancer	1.13e-06	1.02e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ITPR1—breast cancer	1.13e-06	1.02e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—KRAS—breast cancer	1.12e-06	1.01e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ABCB1—breast cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAPK3—breast cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—NOS3—breast cancer	1.11e-06	1e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NCOA3—breast cancer	1.1e-06	9.98e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CB—breast cancer	1.1e-06	9.95e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC2A2—breast cancer	1.09e-06	9.91e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—TYMS—breast cancer	1.09e-06	9.9e-06	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTEN—breast cancer	1.09e-06	9.87e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTGS2—breast cancer	1.09e-06	9.86e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.08e-06	9.85e-06	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—breast cancer	1.08e-06	9.85e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—MYC—breast cancer	1.08e-06	9.79e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTM1—breast cancer	1.08e-06	9.78e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.08e-06	9.78e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NCOR1—breast cancer	1.08e-06	9.78e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—TGFB1—breast cancer	1.08e-06	9.77e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—COMT—breast cancer	1.07e-06	9.75e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CPT1A—breast cancer	1.07e-06	9.71e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MTR—breast cancer	1.07e-06	9.71e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCG2—breast cancer	1.07e-06	9.71e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTP1—breast cancer	1.07e-06	9.71e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—MTHFR—breast cancer	1.07e-06	9.69e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—TYMS—breast cancer	1.06e-06	9.66e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—MTHFR—breast cancer	1.06e-06	9.63e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGFR—breast cancer	1.05e-06	9.58e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—HMOX1—breast cancer	1.05e-06	9.57e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ITPR1—breast cancer	1.05e-06	9.55e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTM1—breast cancer	1.05e-06	9.55e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NCOR1—breast cancer	1.05e-06	9.55e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PLA2G4A—breast cancer	1.05e-06	9.55e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HPGDS—breast cancer	1.05e-06	9.52e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HBA1—breast cancer	1.04e-06	9.46e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GPX1—breast cancer	1.03e-06	9.37e-06	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CA—breast cancer	1.03e-06	9.32e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP1A1—breast cancer	1.02e-06	9.28e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CB—breast cancer	1.02e-06	9.27e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ACHE—breast cancer	1.02e-06	9.24e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTT1—breast cancer	1.02e-06	9.24e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ERCC2—breast cancer	1.01e-06	9.2e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ABCB1—breast cancer	1.01e-06	9.19e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTGS2—breast cancer	1.01e-06	9.19e-06	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—breast cancer	1.01e-06	9.15e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GPX1—breast cancer	1.01e-06	9.15e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP1A1—breast cancer	9.97e-07	9.05e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—KRAS—breast cancer	9.96e-07	9.05e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TYMS—breast cancer	9.94e-07	9.03e-06	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—breast cancer	9.93e-07	9.02e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ERCC2—breast cancer	9.89e-07	8.98e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CAV1—breast cancer	9.84e-07	8.94e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PLA2G4A—breast cancer	9.82e-07	8.92e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTM1—breast cancer	9.82e-07	8.92e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NCOR1—breast cancer	9.82e-07	8.92e-06	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CA—breast cancer	9.78e-07	8.89e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—CAV1—breast cancer	9.78e-07	8.89e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP17A1—breast cancer	9.63e-07	8.74e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ENO1—breast cancer	9.53e-07	8.66e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS1—breast cancer	9.53e-07	8.66e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—MTHFR—breast cancer	9.52e-07	8.65e-06	CbGpPWpGaD
Probenecid—ALB—Hemostasis—HRAS—breast cancer	9.5e-07	8.63e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTEN—breast cancer	9.46e-07	8.59e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GPX1—breast cancer	9.41e-07	8.54e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.4e-07	8.54e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.35e-07	8.49e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2D6—breast cancer	9.35e-07	8.49e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP1A1—breast cancer	9.31e-07	8.46e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—MTHFR—breast cancer	9.29e-07	8.44e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ERCC2—breast cancer	9.24e-07	8.39e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NCOA2—breast cancer	9.18e-07	8.33e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CA—breast cancer	9.15e-07	8.31e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CG—breast cancer	8.96e-07	8.14e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CG—breast cancer	8.91e-07	8.09e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—FASN—breast cancer	8.9e-07	8.08e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—BCHE—breast cancer	8.86e-07	8.05e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTEN—breast cancer	8.82e-07	8.01e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CAV1—breast cancer	8.78e-07	7.98e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC5A5—breast cancer	8.75e-07	7.95e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—MTHFR—breast cancer	8.68e-07	7.88e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CAV1—breast cancer	8.57e-07	7.79e-06	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CA—breast cancer	8.52e-07	7.74e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—HRAS—breast cancer	8.47e-07	7.69e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NQO1—breast cancer	8.45e-07	7.68e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC2A1—breast cancer	8.45e-07	7.68e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.39e-07	7.62e-06	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—breast cancer	8.39e-07	7.62e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6—breast cancer	8.11e-07	7.36e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP1B1—breast cancer	8.1e-07	7.36e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CAV1—breast cancer	8.01e-07	7.27e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CG—breast cancer	8e-07	7.27e-06	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—breast cancer	7.99e-07	7.26e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HSP90AA1—breast cancer	7.95e-07	7.22e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CD—breast cancer	7.88e-07	7.16e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CD—breast cancer	7.83e-07	7.12e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CG—breast cancer	7.81e-07	7.09e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ALB—breast cancer	7.78e-07	7.06e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NCOA1—breast cancer	7.73e-07	7.02e-06	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CA—breast cancer	7.67e-07	6.96e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.65e-07	6.95e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP19A1—breast cancer	7.62e-07	6.92e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—STK11—breast cancer	7.62e-07	6.92e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—breast cancer	7.48e-07	6.79e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NOS3—breast cancer	7.44e-07	6.76e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—NOS3—breast cancer	7.4e-07	6.72e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CG—breast cancer	7.29e-07	6.62e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—COMT—breast cancer	7.08e-07	6.43e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTP1—breast cancer	7.05e-07	6.4e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CD—breast cancer	7.03e-07	6.39e-06	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—breast cancer	6.96e-07	6.32e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HMOX1—breast cancer	6.95e-07	6.31e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ALB—breast cancer	6.94e-07	6.31e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ITPR1—breast cancer	6.94e-07	6.3e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CB—breast cancer	6.87e-07	6.24e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CD—breast cancer	6.86e-07	6.23e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CB—breast cancer	6.83e-07	6.2e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS2—breast cancer	6.81e-07	6.18e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ALB—breast cancer	6.78e-07	6.15e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS2—breast cancer	6.77e-07	6.14e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CA—breast cancer	6.68e-07	6.06e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCB1—breast cancer	6.67e-07	6.06e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NOS3—breast cancer	6.64e-07	6.03e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TYMS—breast cancer	6.55e-07	5.95e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NOS3—breast cancer	6.48e-07	5.89e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PLA2G4A—breast cancer	6.48e-07	5.88e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NCOR1—breast cancer	6.48e-07	5.88e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTM1—breast cancer	6.48e-07	5.88e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CD—breast cancer	6.41e-07	5.82e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ALB—breast cancer	6.33e-07	5.75e-06	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—breast cancer	6.26e-07	5.69e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CA—breast cancer	6.22e-07	5.65e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GPX1—breast cancer	6.2e-07	5.63e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP1A1—breast cancer	6.14e-07	5.58e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CB—breast cancer	6.13e-07	5.57e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ERCC2—breast cancer	6.09e-07	5.53e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS2—breast cancer	6.07e-07	5.52e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NOS3—breast cancer	6.06e-07	5.5e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CB—breast cancer	5.98e-07	5.43e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTEN—breast cancer	5.93e-07	5.39e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS2—breast cancer	5.93e-07	5.38e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTEN—breast cancer	5.9e-07	5.36e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MTHFR—breast cancer	5.73e-07	5.2e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CB—breast cancer	5.59e-07	5.08e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS2—breast cancer	5.54e-07	5.03e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—breast cancer	5.45e-07	4.95e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTEN—breast cancer	5.3e-07	4.81e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CAV1—breast cancer	5.28e-07	4.8e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTEN—breast cancer	5.17e-07	4.7e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—breast cancer	5.08e-07	4.62e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTEN—breast cancer	4.83e-07	4.39e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CG—breast cancer	4.81e-07	4.37e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CD—breast cancer	4.23e-07	3.84e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CA—breast cancer	4.19e-07	3.8e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALB—breast cancer	4.18e-07	3.79e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CA—breast cancer	4.16e-07	3.78e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NOS3—breast cancer	3.99e-07	3.63e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CA—breast cancer	3.74e-07	3.39e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CB—breast cancer	3.69e-07	3.35e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS2—breast cancer	3.65e-07	3.32e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CA—breast cancer	3.65e-07	3.31e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—breast cancer	3.42e-07	3.11e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CA—breast cancer	3.41e-07	3.09e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—breast cancer	3.4e-07	3.09e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTEN—breast cancer	3.19e-07	2.89e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—breast cancer	3.05e-07	2.77e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—breast cancer	2.98e-07	2.71e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—breast cancer	2.78e-07	2.53e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CA—breast cancer	2.25e-07	2.04e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—breast cancer	1.84e-07	1.67e-06	CbGpPWpGaD
